This opportunity is no longer accepting applications.
grant PAR-22-142

NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required)

This grant opportunity invites applications for exploratory clinical trials supported by the National Institute of Neurological Disorders and Stroke (NINDS). It aims to fund early-phase trials (Phase 1 and 2) of drugs, biologics, devices, and therapies related to neurology. The purpose is to provide data that can inform future efficacy trials (such as Phase 3 or Phase 4 trials). The process ut…

The purpose of this Funding Opportunity Announcement (FOA) is to encourage grant applications for investigator-initiated exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The trials must address questions within the mission and research interests…

Funding Source

Agency: National Institutes of Health
Program: SBIR

Dates

Opportunity Released: April 18, 2022
Open for Submission: April 18, 2022
Submission Deadline: March 10, 2025
Application Window Closes: March 10, 2025

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.